Marcus joined Novo Holdings A/S in October 2022 as Partner in the Bioindustrials Team taking part in managing and developing the growing portfolio of investments.
Marcus has more than 25 years of experience with several senior leadership roles across the globe having worked in the US, Germany, Mexico, Austria and the UK. Previously, he was Chief Technology Officer at Royal DSM and prior to that held various positions in the Animal Health Industry including leadership of Biologics and Pharma R&D, global M&A licensing and Country President. Marcus is passionate about innovation and sustainability and also serves as a member of the Global Expert Network of the World Economic Forum.
Marcus holds a doctorate in Polymer Chemistry (1997) from the Max Planck Institute for Polymer Research and a Diploma in Chemistry from the University of Freiburg, Germany.